Compare STAG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STAG | KRYS |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.8B |
| IPO Year | 2010 | 2017 |
| Metric | STAG | KRYS |
|---|---|---|
| Price | $38.01 | $247.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $39.20 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 1.2M | 254.5K |
| Earning Date | 05-13-2026 | 05-18-2026 |
| Dividend Yield | ★ 4.08% | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | N/A | ★ 6.84 |
| Revenue | ★ $845,184,000.00 | $389,130,000.00 |
| Revenue This Year | $8.59 | $40.88 |
| Revenue Next Year | $9.28 | $35.16 |
| P/E Ratio | ★ N/A | $36.71 |
| Revenue Growth | 10.14 | ★ 33.94 |
| 52 Week Low | $28.61 | $123.03 |
| 52 Week High | $39.98 | $298.30 |
| Indicator | STAG | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 38.23 |
| Support Level | $37.91 | $233.64 |
| Resistance Level | $38.72 | $248.60 |
| Average True Range (ATR) | 0.74 | 9.14 |
| MACD | -0.17 | -2.19 |
| Stochastic Oscillator | 25.74 | 9.64 |
Stag Industrial Inc is a real estate investment trust that is involved in the acquisition and operation of both single- and multi-tenant properties, although the majority of the portfolio is single-tenant industrial properties throughout the United States. The vast majority of the company's real estate portfolio is comprised of warehouse and distribution buildings. Stag Industrial derives nearly all of its income in the form of rental income from its portfolio of warehouse and distribution properties. The company generates the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities. Stag Industrial's customers include air freight and logistics, automotive, and industrial equipment companies in terms of overall revenue.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.